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Abstract The effect of Ca2+ on conformational changes in
rhodamine-phalloidin-labeled F-actin induced by binding of
smooth muscle heavy meromyosin (HMM) with either phos-
phorylated or dephosphorylated regulatory light chains (LC20)
was studied by polarized fluorimetry. LC20 phosphorylation
caused alterations in the F-actin structure typical of the force-
producing (strong-binding) state, while dephosphorylation of the
chains led to alterations typical of the formation of non-force-
producing (weak-binding) state of the actomyosin complex. The
presence of Ca2+ enhanced the effect of LC20 phosphorylation
and weakened the effect of LC20 dephosphorylation. These data
suggest that Ca2+ modulates actin-myosin interaction in smooth
muscle by promoting formation of the strong-binding state.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
In smooth muscle cells, Ca2-calmodulin-dependent phos-
phorylation of the 20-kDa light chains of myosin (LC20) plays
a central role in the regulation of contraction [1^3]. It has
been suggested that the level of LC20 phosphorylation regu-
lates the rate of inorganic phosphate release from the active
site of actomyosin ATPase [4]. Therefore, according to the
kinetic model proposed by Eisenberg and Greene [5], LC20
phosphorylation-dephosphorylation a¡ects the transition
from the weak-binding actomyosin complex to the strong-
binding complex. Biochemical evidence suggests that in addi-
tion to its role in LC20 phosphorylation, which represents the
main regulatory pathway for actin-myosin interaction, Ca2
has a direct e¡ect on actin-activated ATPase activity and thus
may modulate the interaction between actin and myosin [6^8].
However, the molecular mechanisms of this modulation have
remained unclear.
In this study, we used polarized £uorimetry, which demon-
strates high sensitivity in evaluating conformational changes
in the contractile proteins [9^15] to study the e¡ect of LC20
phosphorylation and Ca2 on conformational changes in ac-
tomyosin accompanying tension development in smooth
muscle. It is shown that phosphorylated heavy meromyosin
(pHMM) induces changes in actin typical of the force-produc-
ing (strong-binding) state and dephosphorylated HMM
(dpHMM) induces changes in actin typical of the non-force-
producing (weak-binding) state. Ca2 strengthens the e¡ect of
phosphorylation and weakens the e¡ect of dephosphorylation
of myosin regulatory light chains. Thus, LC20 phosphoryla-
tion regulates the relative number of cross-bridges that are in
the force-producing state in the ¢ber, and Ca2 ¢ne-tunes this
regulation.
2. Materials and methods
2.1. Preparation of proteins
Smooth muscle myosin was extracted from chicken gizzards, phos-
phorylated using endogenous kinase, and puri¢ed by gel ¢ltration on
a Sepharose 4B-CL agarose column [16]. HMMs were prepared ac-
cording to Kaminski and Chacko [8]. Phosphorylated myosin was
concentrated and digested with K-chymotrypsin followed by chroma-
tography on a Sepharose 6B-CL column. Dephosphorylated HMM
was obtained by treating the phosphorylated HMM with phosphatase
prepared as described [17]. After dephosphorylation, HMM was again
chromatographed on a Sepharose 6B-CL column to remove the phos-
phatase and then concentrated [8]. The phosphorylation levels of the
column-puri¢ed pHMM and dpHMM were found to be 98^100% and
0^2%, respectively, as determined using urea gel electrophoresis [18].
Myosin subfragment 1 (S1) modi¢ed by NEM (NEM-S1) and pPDM
(pPDM-S1) was prepared from skeletal muscle according to Reisler
[19] and Chalovich et al. [20], respectively. Protein concentration was
determined as described [21].
2.2. Preparation and labeling of ghost ¢bers
Ghost ¢bers were prepared from single glycerinated ¢bers of rabbit
psoas muscle by extraction of myosin and the regulatory proteins as
described [12]. Actin ¢laments were labeled with rhodamine-phalloidin
as described [22] by incubation of the ¢bers in a standard solution
(10 mM KCl, 1 mM MgCl2, 6,7 mM phosphate bu¡er, pH 7.0) con-
taining 40 WM £uorescent dye for 20 min at room temperature. Un-
bound dye was removed by washing the ¢bers in the standard solution
for 15 min at room temperature.
2.3. Binding of HMMs, NEM-S1 and pPDM-S1 to ghost ¢bers
To incorporate pHMM or NEM-S1 ghost ¢bers were immersed for
30 min in 20 mM KCl, 3 mM MgCl2, 10 mM imidazole bu¡er (pH
7.0) and 0.5 mg/ml of the correspondent protein. Incorporation of
dpHMM or pPDM-S1 was carried out in the same solution, contain-
ing 2 mg/ml of the correspondent protein, with incubation for 2 h. Ca/
EGTA bu¡er was used to keep the concentration of free Ca2 in the
incubation mixture at 1035 or 1037 M [23]. After washing the ¢bers in
the standard solution for 15 min at room temperature to remove
unbound protein the ¢bers were monitored for composition by
SDS-PAGE [24]. The molar ratios of HMM, NEM-S1 and pPDM-
S1 bound to actin in ghost ¢bers were approximately 1:10 (S.D., þ 3),
1:5 (S.D., þ 2), and 1:5 (S.D., þ 2), respectively, as determined by
densitometric scanning of the gels (UltroScan XL, Pharmacia LKB).
2.4. Fluorescence polarization measurements
Polarized £uorescence of rhodamine-phalloidin bound to F-actin in
ghost ¢bers was measured in the standard solution before and after
addition of pHMM, dpHMM, NEM-S1 or pPDM-S1 at pCa = 5 and
pCa = 7. Excitation of £uorescence probe was at 489 þ 5 nm and emis-
sion was recorded at 500^600 nm. Intensities of the components of
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polarized £uorescence were measured in parallel NIN, NIP) and in
perpendicular (PIP, PIN) orientation of the ¢ber axis to the pola-
rization plane of the exciting light. Data were analyzed as described
[11,25,26]. The model used is based on the assumption that oscillators
of £uorophores are helically arranged in the ¢ber, along the cone-
shaped surface. The three ratios of £uorescence intensities, NIP/NIN,
PIP/NIN and PIN/NIN were considered functions of angles xA, xE and
31=2, respectively, where xA and xE are angles between the ¢ber axis
and the absorbance and emission dipoles, respectively, and 31=2 is the
angle between the F-actin ¢lament axis and the ¢ber axis. The changes
in xA and xE are interpreted in terms of structural alterations of actin
monomers in the region of £uorophore location and/or their twisting
in ¢laments [11,14,27]. xA changes were found to parallel correspond-
ing xE changes in all experiments; therefore, the values of xA are not
presented. 31=2 is not constant, and instead £uctuates and varies along
each ¢lament due to thermal bending motion. The increase in the
value of 31=2 is considered to re£ect increased £exibility of actin
¢laments in the ¢bers.
The signi¢cance of the di¡erences observed was determined by Stu-
dent’s t-test.
3. Results and discussion
In the present study rhodamine-phalloidin was used as an
extrinsic £uorescent probe speci¢cally attached to F-actin of
the ghost ¢bers. Whereas phalloidin binding to F-actin in-
creases the rigidity of thin ¢laments [28,29], it does not change
the dynamic properties of the protein [30] and a¡ects neither
the tension development of glycerinated muscle ¢bers [30] nor
the activity of actin-activated ATPase of myosin [31]. Ghost
¢bers are characterized by high anisotropy of polarized £uo-
rescence emitted by the £uorophores, indicating a regular ar-
rangement of rhodamine-phalloidin molecules and high ri-
gidity of their bond with actin [32]. Thus, this £uorescent
dye is appropriate for polarized £uorimetry experiments.
We used the complex of pPDM-S1 with F-actin as a model
for the weak-binding state of actomyosin. Although pPDM-
S1 itself may not be a good structural analogue of the S1-ATP
or S1-ADP-Pi complexes [33], pPDM-S1 binds weakly to F-
actin [20], and the orientation of pPDM-modi¢ed S1 relative
to actin ¢lament is the same as that of native S1 in the pres-
ence of ATP [34]. For consistency, a modi¢ed S1, NEM-S1,
was used for the strong-binding conditions (for review, see
[35]).
As shown in Table 1, the values of the angles xE and 31=2
changed when pHMM, dpHMM, NEM-S1 or pPDM-S1 in-
teracted with F-actin in the ghost ¢ber, consistent with the
notion that F-actin interaction with each of the four proteins
is accompanied by conformational changes in thin ¢laments.
Both NEM-S1 and pHMM interaction with F-actin resulted
in a decrease in xE and an increase in 31=2. Consequently, the
conformational state of actin in its complex with pHMM is
similar to that in its complex with NEM-S1. As NEM-S1
complex with F-actin is a model of a force-producing
(strong-binding) state of actomyosin (for review, see [35]), it
is possible to conclude that pHMM forms strong binding with
actin.
By contrast, both pPDM-S1 and dpHMM produced in-
creased xE and decreased 31=2 values (Table 1). Thus the
conformational state of actin in its complex with dpHMM
strongly resembles that in its complex with pPDM-S1. As
pPDM-S1 binds to actin as if it formed weak bonds [20,35],
dpHMM complex with actin is in a weak-binding rather than
in a strong-binding state. This suggestion is supported by
biochemical evidence. LC20 dephosphorylation was shown to
decrease the a⁄nity of HMM for actin [36,37]. Taken togeth-
er, these data indicate that phosphorylation of LC20 shifts the
character of actin-myosin interaction from weak binding to
strong binding and reveal a mechanism by which LC20 phos-
phorylation drives smooth muscle contraction.
Smooth muscle contraction is accompanied by a change in
the level of myosin regulatory light chain phosphorylation
from dephosphorylation at relaxation to phosphorylation at
activation. The initial rise in Ca2 and LC20 phosphorylation
induced by Ca2-calmodulin-dependent myosin light chain
kinase is paralleled by rapid shortening and tension develop-
ment. As the Ca2 concentration decreases, the activity of
myosin light chain phosphatase predominates over the kinase
activity, and the extent of LC20 phosphorylation decreases.
The decrease in phosphorylation correlates with the decrease
in shortening velocity, while the level of force generated re-
mains high [38,39]. This phenomenon is interpreted as the
capacity of regulatory light chains to modify the velocity of
the ATPase cycle through a change in the character of actin-
myosin interaction. Phosphorylation of myosin LC20 is
thought to accelerate Pi release from the complex AM-
ADP-Pi, thus favoring strong binding of myosin heads to
actin [4,40]. Conversely, dephosphorylation of LC20 inhibits
Pi release, repressing the formation of the strong binding state
(stage AM or AM-ADP in the ATP hydrolysis cycle). Our
present data are in good agreement with this concept.
The £uctuations of the polarized £uorescence parameters of
pure actin ¢laments caused by addition or removal of Ca2
from the washing solution were not signi¢cant (Table 1). Sim-
ilarly, no di¡erence was found between the changes of the
parameters resulting from NEM-S1 or pPDM-S1 binding to
F-actin at pCa = 5 and the corresponding changes observed at
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Table 1
Alterations of rhodamine-phalloidin-labeled F-actin in ghost ¢bers induced by binding of pHMM, dpHMM, NEM-S1 and pPDM-S1 in the ab-
sence and presence of Ca2
Conditions xE (‡) 31=2 (‡)
F-actin pCa = 7 54.4 þ 0.1 13.1 þ 0.1
pCa = 5 54.3 þ 0.1 13.2 þ 0.1
F-actin + pPDM-S1 pCa = 7 54.6 þ 0.1 12.6 þ 0.1
F-actin + NEM-S1 pCa = 7 53.1 þ 0.1 14.4 þ 0.1
F-actin + dpHMM pCa = 7 55.8 þ 0.1 12.4 þ 0.2
pCa = 5 54.9 þ 01 13.1 þ 0.2
F-actin + pHMM pCa = 7 53.8 þ 0.1 13.9 þ 0.2
pCa = 5 52.3 þ 0.1 15.9 þ 0.2
xE, the angle of the emission dipole of the dye relative to the F-actin axis. 31=2, the angle between the F-actin axis and the ¢ber long axis. Data are
the mean ( þ S.E.M.) of at least 75 measurements made on 15 ghost ¢bers for each experimental condition.
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pCa = 7 (for these experiments, only the values of xE and 31=2
calculated for pCa = 7 are shown in Table 1).
In contrast, the increase in xE and the decrease in 31=2
resulting from dpHMM binding to F-actin were smaller in
the presence of Ca2 than in its absence. The decrease in
the value of the angle xE and the increase in the value of
the angle 31=2 caused by F-actin interaction with pHMM
were larger in the presence of Ca2 than in its absence. These
data are in a good agreement with previous biochemical evi-
dence indicating that at least in some tissues, Ca2 acts to
increase Mg2-ATPase activity of smooth muscle actomyosin
[6^8]. Together, these observations strongly support the no-
tion that Ca2 modulates the interaction of myosin with actin,
in addition to its e¡ect on phosphorylation.
The presence of Ca2 enhances the transition of actin sub-
units to the state typical of strong-binding actomyosin com-
plex, inhibiting the e¡ect of dpHMM and intensifying the
e¡ect of pHMM on actin conformation. Thus, actin-myosin
interaction is modulated by Ca2 in a way that might enable
some dephosphorylated cross-bridges to form the strong-bind-
ing complex with F-actin in the presence of Ca2 and prevent
some phosphorylated cross-bridges from forming the same
complex in the absence of Ca2. The physiological role of
this modulation by Ca2 might be as follows. At activation,
when Ca2 concentrations increase faster than the level of
LC20 phosphorylation, the presence of Ca2 enables forma-
tion of the strong-binding complex even by some cross-bridges
that are still unphosphorylated. This mechanism facilitates the
triggering of muscle contraction by LC20 phosphorylation. At
maximal activation, Ca2 levels begin to decrease, preventing
further changing of the actin ¢lament state by phosphorylated
cross-bridges and inhibiting the formation of strong binding
between the phosphorylated cross-bridges and actin. This
process conserves ATP and contributes to the high economy
of force production in smooth muscle. At relaxation, low
Ca2 concentrations would decrease ATP hydrolysis, thereby
facilitating the ¢ber relaxation.
Thus, our data indicate that both phosphorylation of my-
osin regulatory light chains and Ca2 can change the charac-
ter of the interaction of myosin heads with F-actin in muscle
¢bers. Phosphorylation of myosin LC20 causes the formation
of the force-producing, strong-binding state, while dephos-
phorylation of the light chains leads to the non-force-produc-
ing, weak-binding state of the actomyosin complex. Ca2 fa-
vors the transition of actin monomers to the state typical of
strong binding and thereby strengthens the e¡ect of phospho-
rylation and weakens the e¡ect of dephosphorylation of
myosin regulatory light chains.
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